CHRISTINE ULRICH: Open Payments
NPI 1619955754 · VAN WERT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 68 payments from 17 companies in 2025. Trend: 2023 $1,829 · 2024 $1,271 · 2025 $941
Food & beverage: $899Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $242 |
| Novo Nordisk Inc | 19 | $211 |
| Mannkind Corporation | 2 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| Indivior Inc. | 2 | $61 |
| Lilly USA, LLC | 3 | $53 |
| Amgen Inc. | 3 | $48 |
| Aimmune Therapeutics, Inc. | 3 | $44 |
| Braeburn Inc. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: VRAYLAR, Ozempic, Wegovy, AFREZZA, CAPLYTA, SUBLOCADE, UBRELVY, MOUNJARO.
Industry payments across OH — which companies pay providers there.
